Search 

see company website

Tianda Pharmaceutical Limited (455.HK) is a Hong Kong listing company, concentrated in the R&D, manufacturing and distribution of biochemicals, biologics, biosimilars, CHC, dietary supplements and TCM.The company has two pharmaceutical factories, one TCM herbal slice plant, one GSP Company, one CSO company and a R&D center, and several operating
platforms separately located in Sydney, Hong Kong, Shenzhen, Zhuhai and Kunming.Shanghai Pharmaceutical Holding Co Limited, one of the top three largest pharmaceutical companies in China, has invested in Tianda Pharmaceuticals.
The mutual parties share their resources, therefore Tianda could explore and develop its business by utilizing the resources of Shanghai Pharmaceuticals.

Tianjin Chase Sun Pharmaceutical Co., Ltd. is a listed pharmaceutical company with market value of over RMB 10 billion.  It's a high-tech pharmaceutical health industry cluster that covers TCM granules, finished drugs, pharmaceutic adjuvants, active pharmaceutical ingredients, medical devices, medical and health management services and other areas.   Since 2015, the company has been ranked among the Top 100 Enterprises in China’s Pharmaceutical Industry.

For many years, Chase Sun has been focusing on researches and innovations in the five drug areas of critical, neoplastic, cardio-cerebrovascular, respiratory and neurodegenerative diseases, and dedicated to reducing China’s ICU fatality rate. It has already developed ace product catalog with independent IPRs represented by Xuebijing® injection and other first-aid medicines for critical diseases. A paper on RCT for Xuebijing’s Efficacy in Treatment of SCAP was published on the authoritative international critical medicine journal of Critical Care Medicine (CCM) in 2019 with corresponding authors of Prof. Bai Chunxue, Zhongshan Hospital, Fudan University and Shang Hongcai, Research Fellow of Dongzhimen Hospital, Beijing University of Chinese Medicine as well as first author of Prof. Song Yuanlin, Zhongshan Hospital, Fudan University. According to research, Xuebijing®reduced fatality rate of patients with severe pneumonia by 8.8%, made significant breakthrough in research methodology for evidence-based traditional Chinese medicine, reflected concrete clinical value of reduction of fatality rate of critical diseases, and created a new treatment pattern featured by combined use of Chinese and western medicine for patients with critical diseases.

Founded in 2007 with a management capital of 10 billion, fousing on healthcare and manufacturing investment. Portfolios includes ASYMCHEN, HOTGENBIO, SUNNOV and other more than 70 companies.

Cro

Tonghua Dongbao Pharmaceutical Co.,LTD is a healthy medicine enterprise which devotes to R&D, manufacturing and sales of high quality pharmaceutics. The company was established in 1985, listed in Shanghai Stocks Exchange in 1994 (600867).By the end of 2019, we have 2,700 employees including 300 R& D persons. Tonghua Dongbao has became a well known industrial manufacturer of recombinant human insulin, and has constructed National enterprise technical center and Post-doctoral Scientific research station.

University

Topscience is specializing in chemical and biological res earch product and service to meet the research needs of global customers. We offers over 80 types of compound liberties and a wide range of high-quality research chemical including inhibitors.，activator， natural compounds，peptides,inhibitory antibodies，and novel life-science kits, for laboratory and scientific use.Besifdes,virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

Currently, TopWin Pharma. has developed to a high-tech group involving the biological and chemical medicine. TopWin Pharmaceutical Group's business has covered all aspects of R&D of new drugs, including clinical research, registration, production and sale. With the mission of "bringing benefits to mankind through innovation and technology", Topwin Group has been cooperating with well-known domestic and international drug R&D institutions to build TopWin Pharma. into a leading domestic and world-class pharmaceutical enterprise.